{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:12:23Z","timestamp":1788567143226,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>RAAS inhibition has been the standard treatment for CKD for years because it can reduce proteinuria and hence retard renal function decline, but the proteinuria reduction effect is still insufficient in many patients. Podocyte foot process and slit diaphragm are the final barrier to prevent serum proteins leak into urine, and podocyte foot process effacement is the common pathway of all proteinruic diseases. Cell structure are regulated by three evolutionarily conserved Rho GTPases, notably, Rac1 activation is sufficient and necessary for podocyte foot process effacement, however, Rac1 inhibition is not an option for kidney disease treatment because of its systemic side effects. Four-and-a-half LIM domains protein 2 (FHL2) is highly expressed in podocytes and has been implicated in regulating diverse biological functions. Here, we used micro-dissected human kidney samples, <jats:italic>in vitro<\/jats:italic> podocyte culture experiments, and a hypertension animal model to determine the possible role of FHL2 in hypertensive nephropathy. FHL2 was abundantly upregulated in hypertensive human glomeruli and animal kidney samples. Genetic deletion of the FHL2 did not alter normal renal structure or function but mitigated hypertension-induced podocyte foot process effacement and albuminuria. Mechanistically, angiotensin II-induced podocyte cytoskeleton reorganization via FAK-Rac1 axis, FHL2 binds with FAK and is an important mediator of Ang II induced Rac1 activation, thus, FHL2 inhibition can selectively block FAK-Rac1 axis in podocyte and prevent proteinuria. These results provide important insights into the mechanisms of podocyte foot process effacement and points out a promising strategy to treat kidney disease.<\/jats:p>","DOI":"10.1038\/s41598-019-42328-1","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T10:04:20Z","timestamp":1556618660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["FHL2 mediates podocyte Rac1 activation and foot process effacement in hypertensive nephropathy"],"prefix":"10.1038","volume":"9","author":[{"given":"Szu-Yuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0361-6348","authenticated-orcid":false,"given":"Pao-Hsien","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Hsun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Han","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1005-3726","authenticated-orcid":false,"given":"Katalin","family":"Susztak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Der-Cherng","family":"Tarng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,30]]},"reference":[{"key":"42328_CR1","first-page":"431","volume":"17","author":"HN Ibrahim","year":"1997","unstructured":"Ibrahim, H. N., Rosenberg, M. E. & Hostetter, T. H. Role of the renin-angiotensin-aldosterone system in the progression of renal disease: a critical review. Seminars in nephrology 17, 431\u2013440 (1997).","journal-title":"Seminars in nephrology"},{"key":"42328_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mce.2013.02.005","volume":"378","author":"R Nistala","year":"2013","unstructured":"Nistala, R. & Whaley-Connell, A. Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin II. Molecular and cellular endocrinology 378, 53\u201358, https:\/\/doi.org\/10.1016\/j.mce.2013.02.005 (2013).","journal-title":"Molecular and cellular endocrinology"},{"key":"42328_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1046\/j.1523-1755.2003.00701.x","volume":"63","author":"NK Hollenberg","year":"2003","unstructured":"Hollenberg, N. K. et al. Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus. Kidney international 63, 172\u2013178, https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00701.x (2003).","journal-title":"Kidney international"},{"key":"42328_CR4","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1159\/000313363","volume":"31","author":"HM Siragy","year":"2010","unstructured":"Siragy, H. M. & Carey, R. M. Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease. American journal of nephrology 31, 541\u2013550, https:\/\/doi.org\/10.1159\/000313363 (2010).","journal-title":"American journal of nephrology"},{"key":"42328_CR5","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1097\/01.ASN.0000127988.42710.A7","volume":"15","author":"S Hoffmann","year":"2004","unstructured":"Hoffmann, S., Podlich, D., Hahnel, B., Kriz, W. & Gretz, N. Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. Journal of the American Society of Nephrology: JASN 15, 1475\u20131487 (2004).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"42328_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev-physiol-020911-153238","volume":"74","author":"A Greka","year":"2012","unstructured":"Greka, A. & Mundel, P. Cell biology and pathology of podocytes. Annual review of physiology 74, 299\u2013323, https:\/\/doi.org\/10.1146\/annurev-physiol-020911-153238 (2012).","journal-title":"Annual review of physiology"},{"key":"42328_CR7","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1128\/MCB.00730-13","volume":"33","author":"H Yu","year":"2013","unstructured":"Yu, H. et al. Rac1 activation in podocytes induces rapid foot process effacement and proteinuria. Molecular and cellular biology 33, 4755\u20134764, https:\/\/doi.org\/10.1128\/MCB.00730-13 (2013).","journal-title":"Molecular and cellular biology"},{"key":"42328_CR8","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.tcb.2007.06.006","volume":"17","author":"C Faul","year":"2007","unstructured":"Faul, C., Asanuma, K., Yanagida-Asanuma, E., Kim, K. & Mundel, P. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends in cell biology 17, 428\u2013437, https:\/\/doi.org\/10.1016\/j.tcb.2007.06.006 (2007).","journal-title":"Trends in cell biology"},{"key":"42328_CR9","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1681\/ASN.2011121206","volume":"23","author":"RP Scott","year":"2012","unstructured":"Scott, R. P. et al. Podocyte-specific loss of Cdc42 leads to congenital nephropathy. Journal of the American Society of Nephrology: JASN 23, 1149\u20131154, https:\/\/doi.org\/10.1681\/ASN.2011121206 (2012).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"42328_CR10","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/ncb0806-781","volume":"8","author":"K Burridge","year":"2006","unstructured":"Burridge, K. & Doughman, R. Front and back by Rho and Rac. Nature cell biology 8, 781\u2013782, https:\/\/doi.org\/10.1038\/ncb0806-781 (2006).","journal-title":"Nature cell biology"},{"key":"42328_CR11","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.cell.2006.09.046","volume":"127","author":"GA Wildenberg","year":"2006","unstructured":"Wildenberg, G. A. et al. p120-catenin and p190RhoGAP regulate cell-cell adhesion by coordinating antagonism between Rac and Rho. Cell 127, 1027\u20131039, https:\/\/doi.org\/10.1016\/j.cell.2006.09.046 (2006).","journal-title":"Cell"},{"key":"42328_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/ki.2009.424","volume":"77","author":"P Mundel","year":"2010","unstructured":"Mundel, P. & Reiser, J. Proteinuria: an enzymatic disease of the podocyte? Kidney international 77, 571\u2013580, https:\/\/doi.org\/10.1038\/ki.2009.424 (2010).","journal-title":"Kidney international"},{"key":"42328_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/nrneph.2011.151","volume":"8","author":"GI Welsh","year":"2012","unstructured":"Welsh, G. I. & Saleem, M. A. The podocyte cytoskeleton\u2013key to a functioning glomerulus in health and disease. Nature reviews. Nephrology 8, 14\u201321, https:\/\/doi.org\/10.1038\/nrneph.2011.151 (2012).","journal-title":"Nature reviews. Nephrology"},{"key":"42328_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.kint.2017.03.010","volume":"92","author":"R Robins","year":"2017","unstructured":"Robins, R. et al. Rac1 activation in podocytes induces the spectrum of nephrotic syndrome. Kidney international 92, 349\u2013364, https:\/\/doi.org\/10.1016\/j.kint.2017.03.010 (2017).","journal-title":"Kidney international"},{"key":"42328_CR15","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/ki.2013.175","volume":"84","author":"SM Blattner","year":"2013","unstructured":"Blattner, S. M. et al. Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury. Kidney international 84, 920\u2013930, https:\/\/doi.org\/10.1038\/ki.2013.175 (2013).","journal-title":"Kidney international"},{"key":"42328_CR16","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1159\/000110458","volume":"20","author":"G Kallergi","year":"2007","unstructured":"Kallergi, G., Agelaki, S., Markomanolaki, H., Georgoulias, V. & Stournaras, C. Activation of FAK\/PI3K\/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cells. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology 20, 977\u2013986, https:\/\/doi.org\/10.1159\/000110458 (2007).","journal-title":"Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"key":"42328_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1091\/mbc.E06-03-0207","volume":"18","author":"F Chang","year":"2007","unstructured":"Chang, F., Lemmon, C. A., Park, D. & Romer, L. H. FAK potentiates Rac1 activation and localization to matrix adhesion sites: a role for betaPIX. Molecular biology of the cell 18, 253\u2013264, https:\/\/doi.org\/10.1091\/mbc.E06-03-0207 (2007).","journal-title":"Molecular biology of the cell"},{"key":"42328_CR18","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1681\/ASN.2011070734","volume":"23","author":"W Kawarazaki","year":"2012","unstructured":"Kawarazaki, W. et al. Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation. Journal of the American Society of Nephrology: JASN 23, 997\u20131007, https:\/\/doi.org\/10.1681\/ASN.2011070734 (2012).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"42328_CR19","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.bbrc.2009.01.142","volume":"380","author":"E Jimenez","year":"2009","unstructured":"Jimenez, E. et al. Angiotensin II induces MMP 2 activity via FAK\/JNK pathway in human endothelial cells. Biochemical and biophysical research communications 380, 769\u2013774, https:\/\/doi.org\/10.1016\/j.bbrc.2009.01.142 (2009).","journal-title":"Biochemical and biophysical research communications"},{"key":"42328_CR20","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1161\/01.RES.87.8.710","volume":"87","author":"G Govindarajan","year":"2000","unstructured":"Govindarajan, G., Eble, D. M., Lucchesi, P. A. & Samarel, A. M. Focal adhesion kinase is involved in angiotensin II-mediated protein synthesis in cultured vascular smooth muscle cells. Circulation research 87, 710\u2013716 (2000).","journal-title":"Circulation research"},{"key":"42328_CR21","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1111\/j.1582-4934.2010.01176.x","volume":"14","author":"T Shathasivam","year":"2010","unstructured":"Shathasivam, T., Kislinger, T. & Gramolini, A. O. Genes, proteins and complexes: the multifaceted nature of FHL family proteins in diverse tissues. Journal of cellular and molecular medicine 14, 2702\u20132720, https:\/\/doi.org\/10.1111\/j.1582-4934.2010.01176.x (2010).","journal-title":"Journal of cellular and molecular medicine"},{"key":"42328_CR22","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1681\/ASN.2014100989","volume":"26","author":"SY Li","year":"2015","unstructured":"Li, S. Y. et al. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease. Journal of the American Society of Nephrology: JASN 26, 3072\u20133084, https:\/\/doi.org\/10.1681\/ASN.2014100989 (2015).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"42328_CR23","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1101\/gr.155697.113","volume":"23","author":"W Ju","year":"2013","unstructured":"Ju, W. et al. Defining cell-type specificity at the transcriptional level in human disease. Genome research 23, 1862\u20131873, https:\/\/doi.org\/10.1101\/gr.155697.113 (2013).","journal-title":"Genome research"},{"key":"42328_CR24","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1161\/ATVBAHA.113.303172","volume":"34","author":"Y Xia","year":"2014","unstructured":"Xia, Y., Jin, X., Yan, J., Entman, M. L. & Wang, Y. CXCR6 plays a critical role in angiotensin II-induced renal injury and fibrosis. Arteriosclerosis, thrombosis, and vascular biology 34, 1422\u20131428, https:\/\/doi.org\/10.1161\/ATVBAHA.113.303172 (2014).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"42328_CR25","doi-asserted-by":"publisher","unstructured":"Li, S. Y. et al. Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation. Kidney international, https:\/\/doi.org\/10.1038\/ki.2014.67 (2014).","DOI":"10.1038\/ki.2014.67"},{"key":"42328_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrm1549","volume":"6","author":"SK Mitra","year":"2005","unstructured":"Mitra, S. K., Hanson, D. A. & Schlaepfer, D. D. Focal adhesion kinase: in command and control of cell motility. Nature reviews. Molecular cell biology 6, 56\u201368, https:\/\/doi.org\/10.1038\/nrm1549 (2005).","journal-title":"Nature reviews. Molecular cell biology"},{"key":"42328_CR27","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1681\/ASN.2009090991","volume":"21","author":"H Ma","year":"2010","unstructured":"Ma, H. et al. Inhibition of podocyte FAK protects against proteinuria and foot process effacement. Journal of the American Society of Nephrology: JASN 21, 1145\u20131156, https:\/\/doi.org\/10.1681\/ASN.2009090991 (2010).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"42328_CR28","first-page":"921","volume":"24","author":"B Gabriel","year":"2004","unstructured":"Gabriel, B. et al. Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer. Anticancer research 24, 921\u2013927 (2004).","journal-title":"Anticancer research"},{"key":"42328_CR29","doi-asserted-by":"publisher","first-page":"E6813","DOI":"10.1073\/pnas.1608210113","volume":"113","author":"N Nakazawa","year":"2016","unstructured":"Nakazawa, N., Sathe, A. R., Shivashankar, G. V. & Sheetz, M. P. Matrix mechanics controls FHL2 movement to the nucleus to activate p21 expression. Proceedings of the National Academy of Sciences of the United States of America 113, E6813\u2013E6822, https:\/\/doi.org\/10.1073\/pnas.1608210113 (2016).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"42328_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000057367","volume":"24","author":"G Wolf","year":"1998","unstructured":"Wolf, G. Link between angiotensin II and TGF-beta in the kidney. Mineral and electrolyte metabolism 24, 174\u2013180 (1998).","journal-title":"Mineral and electrolyte metabolism"},{"key":"42328_CR31","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1007\/s00125-002-0843-4","volume":"45","author":"C Weigert","year":"2002","unstructured":"Weigert, C., Brodbeck, K., Klopfer, K., Haring, H. U. & Schleicher, E. D. Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia. Diabetologia 45, 890\u2013898, https:\/\/doi.org\/10.1007\/s00125-002-0843-4 (2002).","journal-title":"Diabetologia"},{"key":"42328_CR32","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","volume":"369","author":"LF Fried","year":"2013","unstructured":"Fried, L. F. et al. Combined angiotensin inhibition for the treatment of diabetic nephropathy. The New England journal of medicine 369, 1892\u20131903, https:\/\/doi.org\/10.1056\/NEJMoa1303154 (2013).","journal-title":"The New England journal of medicine"},{"key":"42328_CR33","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","volume":"358","author":"O Investigators","year":"2008","unstructured":"Investigators, O. et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. The New England journal of medicine 358, 1547\u20131559, https:\/\/doi.org\/10.1056\/NEJMoa0801317 (2008).","journal-title":"The New England journal of medicine"},{"key":"42328_CR34","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","volume":"367","author":"HH Parving","year":"2012","unstructured":"Parving, H. H. et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. The New England journal of medicine 367, 2204\u20132213, https:\/\/doi.org\/10.1056\/NEJMoa1208799 (2012).","journal-title":"The New England journal of medicine"},{"key":"42328_CR35","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1172\/JCI46458","volume":"121","author":"S Akilesh","year":"2011","unstructured":"Akilesh, S. et al. Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. The Journal of clinical investigation 121, 4127\u20134137, https:\/\/doi.org\/10.1172\/JCI46458 (2011).","journal-title":"The Journal of clinical investigation"},{"key":"42328_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06810-y","volume":"7","author":"JC McCaffrey","year":"2017","unstructured":"McCaffrey, J. C. et al. Glucocorticoid therapy regulates podocyte motility by inhibition of Rac1. Scientific reports 7, 6725, https:\/\/doi.org\/10.1038\/s41598-017-06810-y (2017).","journal-title":"Scientific reports"},{"key":"42328_CR37","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1172\/JCI69134","volume":"123","author":"HY Gee","year":"2013","unstructured":"Gee, H. Y. et al. ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. The Journal of clinical investigation 123, 3243\u20133253, https:\/\/doi.org\/10.1172\/JCI69134 (2013).","journal-title":"The Journal of clinical investigation"},{"key":"42328_CR38","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/nm.1879","volume":"14","author":"S Shibata","year":"2008","unstructured":"Shibata, S. et al. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nature medicine 14, 1370\u20131376, https:\/\/doi.org\/10.1038\/nm.1879 (2008).","journal-title":"Nature medicine"},{"issue":"Suppl 1","key":"42328_CR39","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1600-0722.2011.00904.x","volume":"119","author":"Z Huang","year":"2011","unstructured":"Huang, Z. et al. Epithelial-specific knockout of the Rac1 gene leads to enamel defects. Eur J Oral Sci 119(Suppl 1), 168\u2013176, https:\/\/doi.org\/10.1111\/j.1600-0722.2011.00904.x (2011).","journal-title":"Eur J Oral Sci"},{"key":"42328_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ydbio.2011.09.004","volume":"360","author":"R Maddala","year":"2011","unstructured":"Maddala, R. et al. Rac1 GTPase-deficient mouse lens exhibits defects in shape, suture formation, fiber cell migration and survival. Dev Biol 360, 30\u201343, https:\/\/doi.org\/10.1016\/j.ydbio.2011.09.004 (2011).","journal-title":"Dev Biol"},{"key":"42328_CR41","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.2353\/ajpath.2009.080779","volume":"174","author":"S Liu","year":"2009","unstructured":"Liu, S., Kapoor, M. & Leask, A. Rac1 expression by fibroblasts is required for tissue repair in vivo. The American journal of pathology 174, 1847\u20131856, https:\/\/doi.org\/10.2353\/ajpath.2009.080779 (2009).","journal-title":"The American journal of pathology"},{"key":"42328_CR42","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1073\/pnas.0735923100","volume":"100","author":"A Morlon","year":"2003","unstructured":"Morlon, A. & Sassone-Corsi, P. The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1. Proceedings of the National Academy of Sciences of the United States of America 100, 3977\u20133982 (2003).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"42328_CR43","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/emboj\/19.3.359","volume":"19","author":"JM Muller","year":"2000","unstructured":"Muller, J. M. et al. FHL2, a novel tissue-specific coactivator of the androgen receptor. The EMBO journal 19, 359\u2013369, https:\/\/doi.org\/10.1093\/emboj\/19.3.359 (2000).","journal-title":"The EMBO journal"},{"key":"42328_CR44","doi-asserted-by":"publisher","first-page":"28641","DOI":"10.1074\/jbc.M312894200","volume":"279","author":"T Samson","year":"2004","unstructured":"Samson, T. et al. The LIM-only proteins FHL2 and FHL3 interact with alpha- and beta-subunits of the muscle alpha7beta1 integrin receptor. The Journal of biological chemistry 279, 28641\u201328652, https:\/\/doi.org\/10.1074\/jbc.M312894200 (2004).","journal-title":"The Journal of biological chemistry"},{"key":"42328_CR45","doi-asserted-by":"publisher","first-page":"33669","DOI":"10.1074\/jbc.M002519200","volume":"275","author":"V Wixler","year":"2000","unstructured":"Wixler, V. et al. The LIM-only protein DRAL\/FHL2 binds to the cytoplasmic domain of several alpha and beta integrin chains and is recruited to adhesion complexes. The Journal of biological chemistry 275, 33669\u201333678, https:\/\/doi.org\/10.1074\/jbc.M002519200 (2000).","journal-title":"The Journal of biological chemistry"},{"key":"42328_CR46","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nrc3792","volume":"14","author":"FJ Sulzmaier","year":"2014","unstructured":"Sulzmaier, F. J., Jean, C. & Schlaepfer, D. D. FAK in cancer: mechanistic findings and clinical applications. Nature reviews. Cancer 14, 598\u2013610, https:\/\/doi.org\/10.1038\/nrc3792 (2014).","journal-title":"Nature reviews. Cancer"},{"key":"42328_CR47","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jsgi.2005.10.001","volume":"13","author":"B Gabriel","year":"2006","unstructured":"Gabriel, B. et al. Expression of the transcriptional coregulator FHL2 in human breast cancer: a clinicopathologic study. Journal of the Society for Gynecologic Investigation 13, 69\u201375, https:\/\/doi.org\/10.1016\/j.jsgi.2005.10.001 (2006).","journal-title":"Journal of the Society for Gynecologic Investigation"},{"key":"42328_CR48","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1053\/j.gastro.2006.12.004","volume":"132","author":"J Wang","year":"2007","unstructured":"Wang, J. et al. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis. Gastroenterology 132, 1066\u20131076, https:\/\/doi.org\/10.1053\/j.gastro.2006.12.004 (2007).","journal-title":"Gastroenterology"},{"key":"42328_CR49","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1210\/me.2008-0363","volume":"23","author":"HV Heemers","year":"2009","unstructured":"Heemers, H. V. et al. Androgen modulation of coregulator expression in prostate cancer cells. Molecular endocrinology 23, 572\u2013583, https:\/\/doi.org\/10.1210\/me.2008-0363 (2009).","journal-title":"Molecular endocrinology"},{"key":"42328_CR50","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/ATVBAHA.112.300318","volume":"33","author":"PH Huang","year":"2013","unstructured":"Huang, P. H. et al. Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells. Arteriosclerosis, thrombosis, and vascular biology 33, 709\u2013717, https:\/\/doi.org\/10.1161\/ATVBAHA.112.300318 (2013).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"42328_CR51","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1083\/jcb.105.4.1473","volume":"105","author":"JA Cooper","year":"1987","unstructured":"Cooper, J. A. Effects of cytochalasin and phalloidin on actin. The Journal of cell biology 105, 1473\u20131478 (1987).","journal-title":"The Journal of cell biology"}],"updated-by":[{"DOI":"10.1038\/s41598-019-51739-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42328-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42328-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42328-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T09:09:31Z","timestamp":1671268171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42328-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,30]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["42328"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-42328-1","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-019-51739-z","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,30]]},"assertion":[{"value":"30 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6693"}}